Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 25.7837.28-23.51-14.3564.84

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 25.78 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202525.78
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 25.78
-30.85
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹36,540.4 Cr 1.1% 2.4% -10.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

1.1%

2.4%

-10.8%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses